×
0.0179843909060061 0.0179843909060061 0.00101798439090604 0.0176450627757042 0.0234136409908382 0.0373260943332203 0.0688836104513064 0.0770274855785546
Stockreport

Albireo to Receive More than $55 Million(1) in Nondilutive Cash Payments

ALBIREO PHARMA (ALBO)  More Company Research Source: GlobeNewswire
Last albireo pharma earnings: 5/10 04:01 pm Check Earnings Report
PDF — Elobixibat approved in Japan for the treatment of chronic constipation — — Albireo innovation leads to world’s first approved ileal bile acid transporter (IBAT) inhibitor — BOSTON, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved the new drug application for elobixibat for the treatment of chronic constipation in Japan.  The approval of elobixibat in Japan triggers payments to Albireo subsidiary Elobix AB from EA Pharma Co., Ltd. under the terms of a license agreement and from HealthCare Royalty Partners (HCR), subject to customary closing conditions, under the terms of a royalty monetization agreement announced earlier this year, which together total more than $55 million1. At December 31, 2017, Albireo had approximately $53.5 million in cash and cash equivalents.    “The app [Read more]

IMPACT SNAPSHOT EVENT TIME: ALBO
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS